MUC1 and acute respiratory distress syndrome: After comprehensive assessment, SP-D, KL-6, and CC16 are promising biomarkers aiding the identification of at-risk patients and predictions of mortality which may help to clinically improve the ARDS diagnosis and outcome prediction.